Shift Bioscience Unveils Improved Virtual Cell Model Ranking to Accelerate Gene Target Discovery
Shift Bioscience has unveiled an improved ranking system for virtual cell models, enhancing gene target discovery through better performance metrics in rejuvenation research.
SpliceBio Raises €130M Series B to Advance Stargardt Gene Therapy and Expand Genetic Medicines
SpliceBio has raised €130M in Series B funding to advance its gene therapy for Stargardt disease and expand its pipeline using a proprietary protein splicing platform.